Skip CCR Main Navigation National Cancer Institute National Cancer Institute U.S. National Institutes of Health www.cancer.gov
CCR - For Our Staff| Home |

Our Science – DuBois Website

Wendy D. DuBois

Selected Publications

1)  Nakahashi H, Kwon KR, Resch W, Vian L, Dose M, Stavreva D, Hakim O, Pruett N, Nelson S, Yamane A, Qian J, Dubois W, Welsh S, Phair RD, Pugh BF, Lobanenkov V, Hager GL, Casellas R.
A genome-wide map of CTCF multivalency redefines the CTCF code.
Cell Rep. 3: 1678-89, 2013.
[Journal]
2)  Wu JJ, Liu J, Chen EB, Wang JJ, Cao L, Narayan N, Fergusson MM, Rovira II, Allen M, Springer DA, Lago CU, Zhang S, DuBois W, Ward T, deCabo R, Gavrilova O, Mock B, Finkel T.
Increased mammalian lifespan and a segmental and tissue-specific slowing of aging after genetic reduction of mTOR expression.
Cell Rep. 4: 913-20, 2013.
[Journal]
3)  Zhang X, He Y, Lee KH, Dubois W, Li Z, Wu X, Kovalchuk A, Zhang W, Huang J.
Rap2b, a novel p53 target, regulates p53-mediated pro-survival function.
Cell Cycle. 12: 1279-91, 2013.
[Journal]
4)  Li M, He Y, Dubois W, Wu X, Shi J, Huang J.
Distinct regulatory mechanisms and functions for p53-activated and p53-repressed DNA damage response genes in embryonic stem cells.
Mol. Cell. 46: 30-42, 2012.
[Journal]
5)  LeGrand J, Park ES, Wang H, Gupta S, Owens JD, Nelson PJ, DuBois W, Bair T, Janz S, Mushinski JF.
Global gene expression profiling in mouse plasma cell tumor precursor and bystander cells reveals potential intervention targets for plasma cell neoplasia.
Blood. 119: 1018-28, 2012.
[Journal]
6)  Kovalchuk AL, Ansarah-Sobrinho C, Hakim O, Resch W, Tolarová H, Dubois W, Yamane A, Takizawa M, Klein I, Hager GL, Morse HC, Potter M, Nussenzweig MC, Casellas R.
Mouse model of endemic Burkitt translocations reveals the long-range boundaries of Ig-mediated oncogene deregulation.
Proc. Natl. Acad. Sci. U.S.A. 109: 10972-7, 2012.
[Journal]
7)  Spehalski E, Kovalchuk AL, Collins JT, Liang G, Dubois W, Morse HC, Ferguson DO, Casellas R, Dunnick WA.
Oncogenic Myc translocations are independent of chromosomal location and orientation of the immunoglobulin heavy chain locus.
Proc. Natl. Acad. Sci. U.S.A. 109: 13728-32, 2012.
[Journal]
8)  Liu Z, Yang X, Li Z, McMahon C, Sizer C, Barenboim-Stapleton L, Bliskovsky V, Mock B, Ried T, London WB, Maris J, Khan J, Thiele CJ.
CASZ1, a candidate tumor-suppressor gene, suppresses neuroblastoma tumor growth through reprogramming gene expression.
Cell Death Differ. 18: 1174-83, 2011.
[Journal]
9)  Zhang S, Readinger JA, DuBois W, Janka-Junttila M, Robinson R, Pruitt M, Bliskovsky V, Wu JZ, Sakakibara K, Patel J, Parent CA, Tessarollo L, Schwartzberg PL, Mock BA.
Constitutive reductions in mTOR alter cell size, immune cell development, and antibody production.
Blood. 117: 1228-38, 2011.
[Journal]
10)  Smrz D, Kim MS, Zhang S, Mock BA, Smrzová S, DuBois W, Simakova O, Maric I, Wilson TM, Metcalfe DD, Gilfillan AM.
mTORC1 and mTORC2 differentially regulate homeostasis of neoplastic and non-neoplastic human mast cells.
Blood. 118: 6803-13, 2011.
[Journal]
11)  Rutsch S, Neppalli VT, Shin DM, DuBois W, Morse HC, Goldschmidt H, Janz S.
IL-6 and MYC collaborate in plasma cell tumor formation in mice.
Blood. 115: 1746-54, 2010.
[Journal]
12)  Kuchen S, Resch W, Yamane A, Kuo N, Li Z, Chakraborty T, Wei L, Laurence A, Yasuda T, Peng S, Hu-Li J, Lu K, Dubois W, Kitamura Y, Charles N, Sun HW, Muljo S, Schwartzberg PL, Paul WE, O'Shea J, Rajewsky K, Casellas R.
Regulation of microRNA expression and abundance during lymphopoiesis.
Immunity. 32: 828-39, 2010.
[Journal]
13)  Zhang K, Kagan D, Dubois W, Robinson R, Bliskovsky V, Vass WC, Zhang S, Mock BA.
Mndal, a new interferon-inducible family member, is highly polymorphic, suppresses cell growth and may modify plasmacytoma susceptibility.
Blood. 114: 2952-60, 2009.
[Journal]
Click Here to View Collapsed Bibliography.

This page was last updated on 3/31/2014.